President Joe Biden speaks after 200 million vaccinations (video)

2
672

About VT Editors
VT Editors is a General Posting account managed by Jim W. Dean and Gordon Duff. All content herein is owned and copyrighted by Jim W. Dean and Gordon Duff
ATTENTION READERS
Due to the nature of independent content, VT cannot guarantee content validity.
We ask you to Read Our Content Policy so a clear comprehension of VT's independent non-censored media is understood and given its proper place in the world of news, opinion and media.

All content is owned by author exclusively. Expressed opinions are NOT necessarily the views of VT, other authors, affiliates, advertisers, sponsors, partners or technicians. Some content may be satirical in nature. All images within are full responsibility of author and NOT VT.

About VT - Read Full Policy Notice - Comment Policy

2 COMMENTS

  1. the video is very offensive on the mean of seeing how much death in Usa occurred……
    Biden is too old to be a president, his brain is very insANE FOR WHAT TOLD TO pUTIN WHICH IS A VERY STATIST WHEN bIDEN IS A PUPPET OF DEEP STATE, AND ZIONIST REGIME INSTATED IN uSA FROM MANY YEARS

  2. From CMS – Medicare

    COVID-19 Update: FDA Revoked the EUA for Bamlanivimab When Administered Alone

    On April 16, the FDA revoked the Emergency Use Authorization (EUA) for bamlanivimab, when administered alone, due to a sustained increase in COVID-19 viral variants in the U.S. that are resistant to this antibody therapy. The FDA determined that the known and potential benefits of bamlanivimab, when administered alone, no longer outweigh the known and potential risks.

    Medicare will cover and pay for bamlanivimab, when administered alone, for dates of service from November 10, 2020 – April 16, 2021.

    The FDA indicates that alternative monoclonal antibody therapies remain appropriate to treat COVID-19 patients, and health care providers may continue using these authorized therapies when administered together:

    Casirivimab & imdevimab
    Bamlanivimab & etesevimab

    More Information:

    Fact Sheet for Health Care Providers EUA of Casirivimab and Imdevimab Section 15, Antiviral Resistance
    Fact Sheet for Health Care Providers EUA of Bamlanivimab and Etesevimab Section 15, Antiviral Resistance
    Monoclonal Antibody COVID-19 Infusion webpage
    The Medicare Learning Network®, MLN Connects®, and MLN Matters® are registered
    trademarks of the U.S. Department of Health and Human Services (HHS). Paid for by HHS.

    –>

    what is not identified.. is where these new Gamma Globulin Infusions are failing

Comments are closed.